Epoch Investment Partners, Inc. Meridian Bioscience Inc Transaction History

Epoch Investment Partners, Inc.

  • $21.3 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$23.75 - $31.69 $12.7 Million - $17 Million
-536,358 Reduced 70.62%
223,105 $6.79 Million
Q1 2022

May 13, 2022
BUY
$19.97 - $26.94 $1.12 Million - $1.51 Million
56,136 Added 7.98%
759,463 $19.7 Million
Q4 2021

Feb 11, 2022
BUY
$17.46 - $21.61 $12.3 Million - $15.2 Million
703,327 New
703,327 $14.3 Million

Others Institutions Holding VIVO

# of Institutions
10
Shares Held
113K
Call Options Held
0
Put Options Held
0
View Full List

About MERIDIAN BIOSCIENCE INC

VIVO Quotes by TradingView
  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Epoch Investment Partners, Inc. Portfolio

Follow Epoch Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Epoch Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Epoch Investment Partners, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email